pharmaceutical

Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals

Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals

Samsung plans to spend USD 22 Billion in the next three years on developing artificial intelligence, 5G, automotive electronic parts and biopharmaceuticals. This comes as part of the earlier announced USD 160 Billion investment on research, developm..

Biogen Reports Positive Results on Alzheimer's Trial, Shares Soar

Biogen Reports Positive Results on Alzheimer's Trial, Shares Soar

Biogen Inc. (NASDAQ: BIIB) announced today that the outcome of its large clinical trial consisting of 856 patients regarding an Alzheimer’s drug produced positive results. Together with its Japanese partner, Eisai Co., the experimental dr..

Alibaba places shares into healthcare assets ($1.4 BILLION DEAL)

Alibaba places shares into healthcare assets ($1.4 BILLION DEAL)

Chinese e-commerce business Alibaba Group Holding Ltd (NYSE: BABA) sold some shares of pharmaceutical business to fund purchases of health-related assets through $1.4 billion deal.Alibaba Health Information Technology Ltd., a subsidiary of Alibaba, ..

Shire Shares Surge on Reports of Takeda Takeover Attempt

Shire Shares Surge on Reports of Takeda Takeover Attempt

Shire’s plc (NASDAQ: SHPG) shares surged by 17 percent on Wednesday following Takeda Pharmaceutical potential $40 billion bid midst acquisition and mergers in the pharmaceutical industry, according to CNBC.CNBC said Takeda is in its “pre..

Valeant Pharmaceuticals Posted Q4 Earnings

Valeant Pharmaceuticals Posted Q4 Earnings

On Wednesday, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced its financial results for the fourth quarter of 2017. With revenue missing estimates and earnings beating estimates, shares of the company dropped 9% to $16.84 per share..

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Inc. (NYSE: ABBV) reported its fourth quarter financial results for fiscal year 2017. The pharmaceutical company reported better than expected earnings sending shares 13.5 percent before market close on Friday.For the fourth quarter, AbbVie r..

Teva Pharmaceuticals to Cut 25% of Jobs

Teva Pharmaceuticals to Cut 25% of Jobs

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), based in Israel, is one of the world’s largest makers of generic drugs. The pharmaceutical giant has had a rough year, facing declining prices for generic drugs and the loss of a major branded d..